Contrasting NeurAxis (NASDAQ:NRXS) and Guided Therapeutics (OTCMKTS:GTHP)

Risk & Volatility

Guided Therapeutics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.2, meaning that its share price is 320% more volatile than the S&P 500.

Profitability

This table compares Guided Therapeutics and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guided Therapeutics	N/A	N/A	-151.93%
NeurAxis	-492.76%	N/A	-641.25%

Valuation and Earnings

This table compares Guided Therapeutics and NeurAxis”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guided Therapeutics	$100,000.00	65.49	-$3.49 million	($0.03)	-3.33
NeurAxis	$2.46 million	6.75	-$14.63 million	($1.84)	-1.26

Guided Therapeutics has higher earnings, but lower revenue than NeurAxis. Guided Therapeutics is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

9.7% of Guided Therapeutics shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 66.8% of Guided Therapeutics shares are held by insiders. Comparatively, 15.2% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Guided Therapeutics beats NeurAxis on 6 of the 10 factors compared between the two stocks.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.